STOCK TITAN

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences acquisition
Rhea-AI Summary
TELA Bio, Inc. to present at Gilmartin Group Emerging Growth Company Showcase on September 21st, 2023.
Positive
  • None.
Negative
  • None.

MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy, today announced that the Company will participate in the Gilmartin Group Emerging Growth Company Showcase.

TELA’s management is scheduled to present at the Gilmartin Group Emerging Growth Company Showcase at 9:30 am ET on September 21st, 2023. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@telabio.com    


TELA Bio, Inc.

NASDAQ:TELA

TELA Rankings

TELA Latest News

TELA Stock Data

113.83M
34.43M
4.49%
51.75%
1.22%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
MALVERN